Erratum to: Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial
Erratum to: Neurotherapeutics
The phrase “and family members” should be deleted from the second sentence in Paragraph 1 of Discussion. The correct sentence is:
“Considering past ALS treatment trials, this study is unique for several reasons. Firstly, it was driven by reports from patients who, having been treated for one condition (PBA), reported unexpected benefit upon seemingly unrelated symptoms.”
The sentence starting on line 11, Paragraph 2 of Discussion should read:
Just under half (49%) of the subjects in this study improved by one or more points in the ALSFRS-R bulbar domain with DMQ treatment relative to their response on placebo (26%).